JNJ vs TSLA: Which Is the Better Buy?

Side-by-side comparison of Johnson & Johnson and Tesla, Inc. โ€” fair value, conviction, valuation metrics, and QuantHub research signals. Updated 2026-09-26.
Johnson & Johnson ยท Healthcare
$270.68
+5.7% upside to fair value
Med Conviction Grade C High Quality
VS
Tesla, Inc. ยท Consumer Cyclical
$372.11
+45.0% upside to fair value
Med Conviction Grade C
QuantHub Verdict
TSLA has more upside to fair value (+45.0%). These are model outputs โ€” not personalized investment advice. See all research โ†’
Valuation & Fundamentals
Metric JNJ TSLA
Current Price $270.68 $372.11
Fair Value Estimate $286.05 $539.56
Upside to Fair Value +5.7% +45.0%
Market Cap $652.3B $1,469.7B
Forward P/E โ€” โ€”
EV / EBITDA 20.2x 121.7x
Price / Sales 6.7x 14.2x
Price / FCF 35.3x 209.1x
Revenue Growth YoY +6.6% +25.5%
Gross Margin 67.9% 18.9%
Operating Margin 26.8% 4.2%
Return on Equity 25.7% 4.6%
Dividend Yield 1.95% 0%
FCF Yield 2.83% 0.48%
Analyst Consensus Buy Hold
Investment Thesis
JNJ โ€” Johnson & Johnson
Johnson & Johnson is a 141,700-employee healthcare holding company operating two segments, Innovative Medicine (immunology, oncology, neuroscience, infectious disease, cardiovascular and metabolism, pulmonary hypertension) and MedTech (interventional solutions, orthopaedics, surgery, vision), founded in 1887 and headquartered in New Brunswick, New Jersey. Business quality is high on fundamentals:โ€ฆ
TSLA โ€” Tesla, Inc.
Tesla, Inc. designs, manufactures and sells electric vehicles and energy generation and storage systems, operating through Automotive and Energy Generation and Storage segments with 134,785 full-time employees and a market capitalization of $1,469.67 billion at a share price of $372.11. The business quality is mixed: revenue grew 25.5% year over year in the most recent quarter, but earnings fell โ€ฆ
Accumulation Zones
Metric JNJ TSLA
Zone Low $214.54 $404.67
Zone High $243.14 $458.63
In Buy Zone? No Yes
โ† JNJ Research    TSLA Research โ†’    All Research